{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:40:58Z","timestamp":1791549658187,"version":"4.3.4"},"reference-count":102,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-07937-z","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T20:26:53Z","timestamp":1751488013000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hyperbaric oxygen treatment attenuates naloxone-precipitated opioid withdrawal behaviors and alters microglial activity in male and female mice"],"prefix":"10.1038","volume":"15","author":[{"given":"Meg T.","family":"Southard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Giannotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Thakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinity R.","family":"Willsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia G.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane","family":"Hentges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond M.","family":"Quock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis E.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"7937_CR1","unstructured":"Dydyk, A. M., Jain, N. K. & Gupta, M. in StatPearls (2025)."},{"key":"7937_CR2","unstructured":"Control, C. F. D. Understanding the opioid overdose epidemic. https:\/\/www.cdc.gov\/overdose-prevention\/about\/understanding-the-opioid-overdose-epidemic.html (2024)."},{"key":"7937_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/ADM.0000000000000312","volume":"11","author":"YI Hser","year":"2017","unstructured":"Hser, Y. I. et al. High mortality among patients with opioid use disorder in a large healthcare system. J. Addict. Med. 11, 315\u2013319. https:\/\/doi.org\/10.1097\/ADM.0000000000000312 (2017).","journal-title":"J. Addict. Med."},{"key":"7937_CR4","first-page":"176","volume":"103","author":"BP Smyth","year":"2010","unstructured":"Smyth, B. P., Barry, J., Keenan, E. & Ducray, K. Lapse and relapse following inpatient treatment of opiate dependence. Ir. Med. J. 103, 176\u2013179 (2010).","journal-title":"Ir. Med. J."},{"key":"7937_CR5","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1007\/s00213-023-06370-2","volume":"240","author":"SC Monroe","year":"2023","unstructured":"Monroe, S. C. & Radke, A. K. Opioid withdrawal: role in addiction and neural mechanisms. Psychopharmacol. (Berl). 240, 1417\u20131433. https:\/\/doi.org\/10.1007\/s00213-023-06370-2 (2023).","journal-title":"Psychopharmacol. (Berl)"},{"key":"7937_CR6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jsat.2014.03.004","volume":"47","author":"RD Weiss","year":"2014","unstructured":"Weiss, R. D. et al. Reasons for opioid use among patients with dependence on prescription opioids: the role of chronic pain. J. Subst. Abuse Treat. 47, 140\u2013145. https:\/\/doi.org\/10.1016\/j.jsat.2014.03.004 (2014).","journal-title":"J. Subst. Abuse Treat."},{"key":"7937_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/s0165-1781(98)00024-9","volume":"79","author":"PM Liebmann","year":"1998","unstructured":"Liebmann, P. M. et al. Nervousness and pain sensitivity: II. Changed relation in ex-addicts as a predictor for early relapse. Psychiatry Res. 79, 55\u201358. https:\/\/doi.org\/10.1016\/s0165-1781(98)00024-9 (1998).","journal-title":"Psychiatry Res."},{"key":"7937_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1023\/a:1010375727768","volume":"72","author":"SJ Dennison","year":"2001","unstructured":"Dennison, S. J. Clonidine abuse among opiate addicts. Psychiatr Q. 72, 191\u2013195. https:\/\/doi.org\/10.1023\/a:1010375727768 (2001).","journal-title":"Psychiatr Q."},{"key":"7937_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jsat.2010.03.014","volume":"39","author":"Z Schuman-Olivier","year":"2010","unstructured":"Schuman-Olivier, Z. et al. Self-treatment: illicit buprenorphine use by opioid-dependent treatment seekers. J. Subst. Abuse Treat. 39, 41\u201350. https:\/\/doi.org\/10.1016\/j.jsat.2010.03.014 (2010).","journal-title":"J. Subst. Abuse Treat."},{"key":"7937_CR10","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.addbeh.2006.05.022","volume":"32","author":"SE McCabe","year":"2007","unstructured":"McCabe, S. E., Cranford, J. A., Boyd, C. J. & Teter, C. J. Motives, diversion and routes of administration associated with nonmedical use of prescription opioids. Addict. Behav. 32, 562\u2013575. https:\/\/doi.org\/10.1016\/j.addbeh.2006.05.022 (2007).","journal-title":"Addict. Behav."},{"key":"7937_CR11","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1111\/add.15818","volume":"117","author":"KE Torres-Lockhart","year":"2022","unstructured":"Torres-Lockhart, K. E., Lu, T. Y., Weimer, M. B., Stein, M. R. & Cunningham, C. O. Clinical management of opioid withdrawal. Addiction 117, 2540\u20132550. https:\/\/doi.org\/10.1111\/add.15818 (2022).","journal-title":"Addiction"},{"key":"7937_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2011.05.033","volume":"119","author":"KE Dunn","year":"2011","unstructured":"Dunn, K. E., Sigmon, S. C., Strain, E. C., Heil, S. H. & Higgins, S. T. The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: a review. Drug Alcohol Depend. 119, 1\u20139. https:\/\/doi.org\/10.1016\/j.drugalcdep.2011.05.033 (2011).","journal-title":"Drug Alcohol Depend."},{"key":"7937_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.2147\/IJGM.S172460","volume":"11","author":"R Choudhury","year":"2018","unstructured":"Choudhury, R. Hypoxia and hyperbaric oxygen therapy: a review. Int. J. Gen. Med. 11, 431\u2013442. https:\/\/doi.org\/10.2147\/IJGM.S172460 (2018).","journal-title":"Int. J. Gen. Med."},{"key":"7937_CR14","doi-asserted-by":"publisher","unstructured":"Ortega, M. A. et al. A general overview on the hyperbaric oxygen therapy: applications, mechanisms and translational opportunities. Med. (Kaunas). 57. https:\/\/doi.org\/10.3390\/medicina57090864 (2021).","DOI":"10.3390\/medicina57090864"},{"key":"7937_CR15","doi-asserted-by":"publisher","unstructured":"Thom, S. R. & 131S-141S. Hyperbaric oxygen: its mechanisms and efficacy. Plast. Reconstr. Surg. 127 (Suppl 1). https:\/\/doi.org\/10.1097\/PRS.0b013e3181fbe2bf (2011).","DOI":"10.1097\/PRS.0b013e3181fbe2bf"},{"key":"7937_CR16","unstructured":"Weaver, L. K. Hyperbaric Oxygen Therapy Indications (Best Publishing Company, 2014)."},{"key":"7937_CR17","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.brainres.2016.08.017","volume":"1648","author":"D Nicoara","year":"2016","unstructured":"Nicoara, D. et al. Hyperbaric oxygen treatment suppresses withdrawal signs in morphine-dependent mice. Brain Res. 1648, 434\u2013437. https:\/\/doi.org\/10.1016\/j.brainres.2016.08.017 (2016).","journal-title":"Brain Res."},{"key":"7937_CR18","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.pmn.2022.03.001","volume":"23","author":"M Wilson","year":"2022","unstructured":"Wilson, M., Bindler, R. J., Stanek, K., Layton, M. E. & Quock, R. M. Hyperbaric oxygen therapy for pain, opioid withdrawal, and related symptoms: A pilot randomized controlled trial. Pain Manag Nurs. 23, 616\u2013624. https:\/\/doi.org\/10.1016\/j.pmn.2022.03.001 (2022).","journal-title":"Pain Manag Nurs."},{"key":"7937_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/JAN.0000000000000447","volume":"33","author":"M Wilson","year":"2022","unstructured":"Wilson, M. et al. Hyperbaric oxygen to assist adults with opioid use disorder in reducing methadone dose. J. Addict. Nurs. 33, 27\u201336. https:\/\/doi.org\/10.1097\/JAN.0000000000000447 (2022).","journal-title":"J. Addict. Nurs."},{"key":"7937_CR20","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1007\/s11064-017-2447-x","volume":"43","author":"C Chen","year":"2018","unstructured":"Chen, C. et al. Hyperbaric oxygen attenuates withdrawal symptoms by regulating monoaminergic neurotransmitters and NO signaling pathway at nucleus accumbens in Morphine-Dependent rats. Neurochem Res. 43, 531\u2013539. https:\/\/doi.org\/10.1007\/s11064-017-2447-x (2018).","journal-title":"Neurochem Res."},{"key":"7937_CR21","unstructured":"Yepifanova, N. M. Hyperbaric oxygenation in the treatment of patients with opioid addiction, substance addiction and alcoholism in the post-intoxication and abstinence periods. Anesthesiol. Resusit. Sci. (1995)."},{"key":"7937_CR22","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1016\/j.neuroscience.2010.02.011","volume":"167","author":"MR Hutchinson","year":"2010","unstructured":"Hutchinson, M. R. et al. Possible involvement of toll-like receptor 4\/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences. Neuroscience 167, 880\u2013893. https:\/\/doi.org\/10.1016\/j.neuroscience.2010.02.011 (2010).","journal-title":"Neuroscience"},{"key":"7937_CR23","doi-asserted-by":"publisher","first-page":"11187","DOI":"10.1523\/JNEUROSCI.0684-12.2012","volume":"32","author":"MR Hutchinson","year":"2012","unstructured":"Hutchinson, M. R. et al. Opioid activation of toll-like receptor 4 contributes to drug reinforcement. J. Neurosci. 32, 11187\u201311200. https:\/\/doi.org\/10.1523\/JNEUROSCI.0684-12.2012 (2012).","journal-title":"J. Neurosci."},{"key":"7937_CR24","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1124\/pr.110.004135","volume":"63","author":"MR Hutchinson","year":"2011","unstructured":"Hutchinson, M. R. et al. Exploring the neuroimmunopharmacology of opioids: an integrative review of mechanisms of central immune signaling and their implications for opioid analgesia. Pharmacol. Rev. 63, 772\u2013810. https:\/\/doi.org\/10.1124\/pr.110.004135 (2011).","journal-title":"Pharmacol. Rev."},{"key":"7937_CR25","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/164_2022_586","volume":"276","author":"J Liu","year":"2022","unstructured":"Liu, J., Li, J. X., Wu, R. & Toll-Like Receptor 4: A novel target to tackle drug addiction?? Handb. Exp. Pharmacol. 276, 275\u2013290. https:\/\/doi.org\/10.1007\/164_2022_586 (2022).","journal-title":"Handb. Exp. Pharmacol."},{"key":"7937_CR26","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.tips.2009.08.002","volume":"30","author":"LR Watkins","year":"2009","unstructured":"Watkins, L. R., Hutchinson, M. R., Rice, K. C. & Maier, S. F. The toll of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol. Sci. 30, 581\u2013591. https:\/\/doi.org\/10.1016\/j.tips.2009.08.002 (2009).","journal-title":"Trends Pharmacol. Sci."},{"key":"7937_CR27","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1523\/JNEUROSCI.2516-12.2013","volume":"33","author":"JM Schwarz","year":"2013","unstructured":"Schwarz, J. M. & Bilbo, S. D. Adolescent morphine exposure affects long-term microglial function and later-life relapse liability in a model of addiction. J. Neurosci. 33, 961\u2013971. https:\/\/doi.org\/10.1523\/JNEUROSCI.2516-12.2013 (2013).","journal-title":"J. Neurosci."},{"key":"7937_CR28","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.bbi.2011.03.016","volume":"25","author":"L Liu","year":"2011","unstructured":"Liu, L., Coller, J. K., Watkins, L. R., Somogyi, A. A. & Hutchinson, M. R. Naloxone-precipitated morphine withdrawal behavior and brain IL-1beta expression: comparison of different mouse strains. Brain Behav. Immun. 25, 1223\u20131232. https:\/\/doi.org\/10.1016\/j.bbi.2011.03.016 (2011).","journal-title":"Brain Behav. Immun."},{"key":"7937_CR29","doi-asserted-by":"publisher","first-page":"1499799","DOI":"10.3389\/fphar.2024.1499799","volume":"15","author":"X Zhang","year":"2024","unstructured":"Zhang, X., Jin, T., Wang, H., Han, S. & Liang, Y. Microglia in morphine tolerance: cellular and molecular mechanisms and therapeutic potential. Front. Pharmacol. 15, 1499799. https:\/\/doi.org\/10.3389\/fphar.2024.1499799 (2024).","journal-title":"Front. Pharmacol."},{"key":"7937_CR30","doi-asserted-by":"publisher","first-page":"6264","DOI":"10.1038\/s41467-024-50657-7","volume":"15","author":"CHT Kwok","year":"2024","unstructured":"Kwok, C. H. T. et al. Pannexin-1 channel Inhibition alleviates opioid withdrawal in rodents by modulating locus coeruleus to spinal cord circuitry. Nat. Commun. 15, 6264. https:\/\/doi.org\/10.1038\/s41467-024-50657-7 (2024).","journal-title":"Nat. Commun."},{"key":"7937_CR31","doi-asserted-by":"publisher","first-page":"e12027","DOI":"10.1002\/jev2.12027","volume":"10","author":"K Liao","year":"2020","unstructured":"Liao, K. et al. Morphine-mediated release of miR-138 in astrocyte-derived extracellular vesicles promotes microglial activation. J. Extracell. Vesicles. 10, e12027. https:\/\/doi.org\/10.1002\/jev2.12027 (2020).","journal-title":"J. Extracell. Vesicles"},{"key":"7937_CR32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.bbi.2008.09.012","volume":"23","author":"MR Hutchinson","year":"2009","unstructured":"Hutchinson, M. R. et al. Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast). Brain Behav. Immun. 23, 240\u2013250. https:\/\/doi.org\/10.1016\/j.bbi.2008.09.012 (2009).","journal-title":"Brain Behav. Immun."},{"key":"7937_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.brainres.2015.08.011","volume":"1627","author":"L Yang","year":"2015","unstructured":"Yang, L. et al. Hyperbaric oxygen preconditioning attenuates neuroinflammation after intracerebral hemorrhage in rats by regulating microglia characteristics. Brain Res. 1627, 21\u201330. https:\/\/doi.org\/10.1016\/j.brainres.2015.08.011 (2015).","journal-title":"Brain Res."},{"key":"7937_CR34","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1016\/j.jss.2013.04.070","volume":"184","author":"SW Lim","year":"2013","unstructured":"Lim, S. W. et al. Microglial activation induced by traumatic brain injury is suppressed by postinjury treatment with hyperbaric oxygen therapy. J. Surg. Res. 184, 1076\u20131084. https:\/\/doi.org\/10.1016\/j.jss.2013.04.070 (2013).","journal-title":"J. Surg. Res."},{"key":"7937_CR35","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nature16954","volume":"530","author":"Y Zhu","year":"2016","unstructured":"Zhu, Y., Wienecke, C. F., Nachtrab, G. & Chen, X. A thalamic input to the nucleus accumbens mediates opiate dependence. Nature 530, 219\u2013222. https:\/\/doi.org\/10.1038\/nature16954 (2016).","journal-title":"Nature"},{"key":"7937_CR36","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.tins.2021.03.001","volume":"44","author":"MA Penzo","year":"2021","unstructured":"Penzo, M. A. & Gao, C. The paraventricular nucleus of the thalamus: an integrative node underlying homeostatic behavior. Trends Neurosci. 44, 538\u2013549. https:\/\/doi.org\/10.1016\/j.tins.2021.03.001 (2021).","journal-title":"Trends Neurosci."},{"key":"7937_CR37","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.neubiorev.2015.08.005","volume":"56","author":"GJ Kirouac","year":"2015","unstructured":"Kirouac, G. J. Placing the paraventricular nucleus of the thalamus within the brain circuits that control behavior. Neurosci. Biobehav Rev. 56, 315\u2013329. https:\/\/doi.org\/10.1016\/j.neubiorev.2015.08.005 (2015).","journal-title":"Neurosci. Biobehav Rev."},{"key":"7937_CR38","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1523\/JNEUROSCI.1766-22.2023","volume":"43","author":"G Hou","year":"2023","unstructured":"Hou, G. et al. Opioid receptors modulate firing and synaptic transmission in the paraventricular nucleus of the thalamus. J. Neurosci. 43, 2682\u20132695. https:\/\/doi.org\/10.1523\/JNEUROSCI.1766-22.2023 (2023).","journal-title":"J. Neurosci."},{"key":"7937_CR39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3389\/fnbeh.2020.00075","volume":"14","author":"G McKendrick","year":"2020","unstructured":"McKendrick, G. et al. Ketamine blocks Morphine-Induced conditioned place preference and Anxiety-Like behaviors in mice. Front. Behav. Neurosci. 14, 75. https:\/\/doi.org\/10.3389\/fnbeh.2020.00075 (2020).","journal-title":"Front. Behav. Neurosci."},{"key":"7937_CR40","doi-asserted-by":"publisher","DOI":"10.1101\/2024.07.07.602350","author":"K Goss","year":"2024","unstructured":"Goss, K. et al. Quantifying social roles in multi-animal videos using subject-aware deep-learning. BioRxiv https:\/\/doi.org\/10.1101\/2024.07.07.602350 (2024).","journal-title":"BioRxiv"},{"key":"7937_CR41","doi-asserted-by":"publisher","first-page":"100415","DOI":"10.1016\/j.crmeth.2023.100415","volume":"3","author":"Y Hu","year":"2023","unstructured":"Hu, Y. et al. Quantification of user-defined animal behaviors using learning-based holistic assessment. Cell. Rep. Methods. 3, 100415. https:\/\/doi.org\/10.1016\/j.crmeth.2023.100415 (2023). LabGym.","journal-title":"Cell. Rep. Methods"},{"key":"7937_CR42","doi-asserted-by":"publisher","first-page":"6169","DOI":"10.1073\/pnas.0631749100","volume":"100","author":"T Hikida","year":"2003","unstructured":"Hikida, T., Kitabatake, Y., Pastan, I. & Nakanishi, S. Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine. Proc. Natl. Acad. Sci. U S A. 100, 6169\u20136173. https:\/\/doi.org\/10.1073\/pnas.0631749100 (2003).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"7937_CR43","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.bbr.2006.02.009","volume":"170","author":"F Papaleo","year":"2006","unstructured":"Papaleo, F. & Contarino, A. Gender- and morphine dose-linked expression of spontaneous somatic opiate withdrawal in mice. Behav. Brain Res. 170, 110\u2013118. https:\/\/doi.org\/10.1016\/j.bbr.2006.02.009 (2006).","journal-title":"Behav. Brain Res."},{"key":"7937_CR44","doi-asserted-by":"publisher","first-page":"e0121125","DOI":"10.1371\/journal.pone.0121125","volume":"10","author":"JA Garcia-Carmona","year":"2015","unstructured":"Garcia-Carmona, J. A., Baroja-Mazo, A., Milanes, M. V. & Laorden, M. L. Sex differences between CRF1 receptor deficient mice following naloxone-precipitated morphine withdrawal in a conditioned place aversion paradigm: implication of HPA axis. PLoS One. 10, e0121125. https:\/\/doi.org\/10.1371\/journal.pone.0121125 (2015).","journal-title":"PLoS One"},{"key":"7937_CR45","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/s0091-3057(02)00740-2","volume":"72","author":"TJ Cicero","year":"2002","unstructured":"Cicero, T. J., Nock, B. & Meyer, E. R. Gender-linked differences in the expression of physical dependence in the rat. Pharmacol. Biochem. Behav. 72, 691\u2013697. https:\/\/doi.org\/10.1016\/s0091-3057(02)00740-2 (2002).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"7937_CR46","doi-asserted-by":"publisher","unstructured":"Kalamarides, D. J., Singh, A. & Dani, J. A. Protracted opioid withdrawal behaviors are reduced by nitric oxide Inhibition in mice. Addict. Neurosci. 12 https:\/\/doi.org\/10.1016\/j.addicn.2024.100167 (2024).","DOI":"10.1016\/j.addicn.2024.100167"},{"key":"7937_CR47","doi-asserted-by":"publisher","first-page":"8460","DOI":"10.1038\/s41598-023-35673-9","volume":"13","author":"DJ Kalamarides","year":"2023","unstructured":"Kalamarides, D. J., Singh, A., Wolfman, S. L. & Dani, J. A. Sex differences in VTA GABA transmission and plasticity during opioid withdrawal. Sci. Rep. 13, 8460. https:\/\/doi.org\/10.1038\/s41598-023-35673-9 (2023).","journal-title":"Sci. Rep."},{"key":"7937_CR48","doi-asserted-by":"publisher","first-page":"9767","DOI":"10.1038\/s41598-024-60759-3","volume":"14","author":"D Ozdemir","year":"2024","unstructured":"Ozdemir, D., Meyer, J., Kieffer, B. L. & Darcq, E. Model of negative affect induced by withdrawal from acute and chronic morphine administration in male mice. Sci. Rep. 14, 9767. https:\/\/doi.org\/10.1038\/s41598-024-60759-3 (2024).","journal-title":"Sci. Rep."},{"key":"7937_CR49","doi-asserted-by":"publisher","first-page":"115169","DOI":"10.1016\/j.bbr.2024.115169","volume":"472","author":"MM Morgan","year":"2024","unstructured":"Morgan, M. M. & Nguyen, K. D. Diurnal sex differences in morphine withdrawal revealed by continuous assessment of voluntary home cage wheel running in the rat. Behav. Brain Res. 472, 115169. https:\/\/doi.org\/10.1016\/j.bbr.2024.115169 (2024).","journal-title":"Behav. Brain Res."},{"key":"7937_CR50","doi-asserted-by":"publisher","first-page":"1211188","DOI":"10.3389\/fninf.2023.1211188","volume":"17","author":"J Reddaway","year":"2023","unstructured":"Reddaway, J., Richardson, P. E., Bevan, R. J., Stoneman, J. & Palombo, M. Microglial morphometric analysis: so many options, so little consistency. Front. Neuroinform. 17, 1211188. https:\/\/doi.org\/10.3389\/fninf.2023.1211188 (2023).","journal-title":"Front. Neuroinform"},{"key":"7937_CR51","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1002\/jnr.24683","volume":"99","author":"BM Siemsen","year":"2021","unstructured":"Siemsen, B. M. et al. Chronic intermittent ethanol and lipopolysaccharide exposure differentially alter Iba1-derived microglia morphology in the prelimbic cortex and nucleus accumbens core of male Long-Evans rats. J. Neurosci. Res. 99, 1922\u20131939. https:\/\/doi.org\/10.1002\/jnr.24683 (2021).","journal-title":"J. Neurosci. Res."},{"key":"7937_CR52","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3109\/00952990.2011.596982","volume":"37","author":"SE Back","year":"2011","unstructured":"Back, S. E. et al. Comparative profiles of men and women with opioid dependence: results from a National multisite effectiveness trial. Am. J. Drug Alcohol Abuse. 37, 313\u2013323. https:\/\/doi.org\/10.3109\/00952990.2011.596982 (2011).","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"7937_CR53","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2478\/acph-2023-0018","volume":"73","author":"J Muriel","year":"2023","unstructured":"Muriel, J. et al. Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences. Acta Pharm. 73, 227\u2013241. https:\/\/doi.org\/10.2478\/acph-2023-0018 (2023).","journal-title":"Acta Pharm."},{"key":"7937_CR54","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/s0091-3057(99)00174-4","volume":"65","author":"TJ Cicero","year":"2000","unstructured":"Cicero, T. J., Ennis, T., Ogden, J. & Meyer, E. R. Gender differences in the reinforcing properties of morphine. Pharmacol. Biochem. Behav. 65, 91\u201396. https:\/\/doi.org\/10.1016\/s0091-3057(99)00174-4 (2000).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"7937_CR55","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1037\/a0012931","volume":"16","author":"RM Craft","year":"2008","unstructured":"Craft, R. M. Sex differences in analgesic, reinforcing, discriminative, and motoric effects of opioids. Exp. Clin. Psychopharmacol. 16, 376\u2013385. https:\/\/doi.org\/10.1037\/a0012931 (2008).","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"7937_CR56","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s00213-020-05479-y","volume":"237","author":"A Kimbrough","year":"2020","unstructured":"Kimbrough, A. et al. Oxycodone self-administration and withdrawal behaviors in male and female Wistar rats. Psychopharmacol. (Berl). 237, 1545\u20131555. https:\/\/doi.org\/10.1007\/s00213-020-05479-y (2020).","journal-title":"Psychopharmacol. (Berl)"},{"key":"7937_CR57","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1093\/pm\/pny295","volume":"20","author":"AS Huhn","year":"2019","unstructured":"Huhn, A. S., Tompkins, D. A., Campbell, C. M. & Dunn, K. E. Individuals with chronic pain who misuse prescription opioids report Sex-Based differences in pain and opioid withdrawal. Pain Med. 20, 1942\u20131947. https:\/\/doi.org\/10.1093\/pm\/pny295 (2019).","journal-title":"Pain Med."},{"key":"7937_CR58","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0022-3565(24)36831-4","volume":"282","author":"TJ Cicero","year":"1997","unstructured":"Cicero, T. J., Nock, B. & Meyer, E. R. Sex-related differences in morphine\u2019s antinociceptive activity: relationship to serum and brain morphine concentrations. J. Pharmacol. Exp. Ther. 282, 939\u2013944 (1997).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"7937_CR59","doi-asserted-by":"publisher","first-page":"173451","DOI":"10.1016\/j.pbb.2022.173451","volume":"219","author":"MM Morgan","year":"2022","unstructured":"Morgan, M. M. & Ataras, K. Sex differences in the impact of pain, morphine administration and morphine withdrawal on quality of life in rats. Pharmacol. Biochem. Behav. 219, 173451. https:\/\/doi.org\/10.1016\/j.pbb.2022.173451 (2022).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"7937_CR60","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/FBP.0000000000000714","volume":"34","author":"AL Brewer","year":"2023","unstructured":"Brewer, A. L. et al. Modeling spontaneous opioid withdrawal in male and female outbred mice using traditional endpoints and hyperalgesia. Behav. Pharmacol. 34, 112\u2013122. https:\/\/doi.org\/10.1097\/FBP.0000000000000714 (2023).","journal-title":"Behav. Pharmacol."},{"key":"7937_CR61","doi-asserted-by":"publisher","first-page":"363","DOI":"10.3109\/00952997609077204","volume":"3","author":"K Blum","year":"1976","unstructured":"Blum, K., Eubanks, J. D., Wiggins, B. & Wallace, J. E. Morphine withdrawal reactions in male and female mice. Am. J. Drug Alcohol Abuse. 3, 363\u2013368. https:\/\/doi.org\/10.3109\/00952997609077204 (1976).","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"7937_CR62","doi-asserted-by":"publisher","first-page":"e12748","DOI":"10.1111\/adb.12748","volume":"25","author":"BR Luster","year":"2020","unstructured":"Luster, B. R. et al. Inhibitory transmission in the bed nucleus of the stria terminalis in male and female mice following morphine withdrawal. Addict. Biol. 25, e12748. https:\/\/doi.org\/10.1111\/adb.12748 (2020).","journal-title":"Addict. Biol."},{"key":"7937_CR63","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/0306-3623(94)90181-3","volume":"25","author":"AO el-Kadi","year":"1994","unstructured":"el-Kadi, A. O. & Sharif, S. I. The influence of various experimental conditions on the expression of naloxone-induced withdrawal symptoms in mice. Gen. Pharmacol. 25, 1505\u20131510. https:\/\/doi.org\/10.1016\/0306-3623(94)90181-3 (1994).","journal-title":"Gen. Pharmacol."},{"key":"7937_CR64","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/00008877-200102000-00009","volume":"12","author":"SL Diaz","year":"2001","unstructured":"Diaz, S. L., Kemmling, A. K., Rubio, M. C. & Balerio, G. N. Lack of sex-related differences in the prevention by Baclofen of the morphine withdrawal syndrome in mice. Behav. Pharmacol. 12, 75\u201379. https:\/\/doi.org\/10.1097\/00008877-200102000-00009 (2001).","journal-title":"Behav. Pharmacol."},{"key":"7937_CR65","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.neulet.2019.04.057","volume":"705","author":"SAM Bobzean","year":"2019","unstructured":"Bobzean, S. A. M., Kokane, S. S., Butler, B. D. & Perrotti, L. I. Sex differences in the expression of morphine withdrawal symptoms and associated activity in the tail of the ventral tegmental area. Neurosci. Lett. 705, 124\u2013130. https:\/\/doi.org\/10.1016\/j.neulet.2019.04.057 (2019).","journal-title":"Neurosci. Lett."},{"key":"7937_CR66","doi-asserted-by":"publisher","first-page":"S353","DOI":"10.33549\/physiolres.934348","volume":"68","author":"V Borbelyova","year":"2019","unstructured":"Borbelyova, V., Janisova, K., Myslivecek, J. & Riljak, V. Sex-related differences in locomotion and climbing of C57Bl\/6NTac mice in a novel environment. Physiol. Res. 68, S353\u2013S359. https:\/\/doi.org\/10.33549\/physiolres.934348 (2019).","journal-title":"Physiol. Res."},{"key":"7937_CR67","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.pbb.2005.10.012","volume":"82","author":"SL Diaz","year":"2005","unstructured":"Diaz, S. L., Kemmling, A. K., Rubio, M. C. & Balerio, G. N. Morphine withdrawal syndrome: involvement of the dopaminergic system in prepubertal male and female mice. Pharmacol. Biochem. Behav. 82, 601\u2013607. https:\/\/doi.org\/10.1016\/j.pbb.2005.10.012 (2005).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"7937_CR68","doi-asserted-by":"publisher","first-page":"1141980","DOI":"10.3389\/fpsyt.2023.1141980","volume":"14","author":"KE Dunn","year":"2023","unstructured":"Dunn, K. E. et al. Operational definition of precipitated opioid withdrawal. Front. Psychiatry. 14, 1141980. https:\/\/doi.org\/10.3389\/fpsyt.2023.1141980 (2023).","journal-title":"Front. Psychiatry"},{"key":"7937_CR69","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S0022-3565(25)11239-1","volume":"260","author":"PD Kanof","year":"1992","unstructured":"Kanof, P. D. et al. Clinical characteristics of naloxone-precipitated withdrawal in human opioid-dependent subjects. J. Pharmacol. Exp. Ther. 260, 355\u2013363 (1992).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"7937_CR70","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0091-3057(89)90306-7","volume":"34","author":"JK Belknap","year":"1989","unstructured":"Belknap, J. K. Components of the opioid withdrawal syndrome in mice are thermoregulatory responses. Pharmacol. Biochem. Behav. 34, 241\u2013245. https:\/\/doi.org\/10.1016\/0091-3057(89)90306-7 (1989).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"7937_CR71","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.bbi.2022.02.001","volume":"102","author":"JHL Thomas","year":"2022","unstructured":"Thomas, J. H. L. et al. Toll-like receptors change morphine-induced antinociception, tolerance and dependence: studies using male and female TLR and signalling gene KO mice. Brain Behav. Immun. 102, 71\u201385. https:\/\/doi.org\/10.1016\/j.bbi.2022.02.001 (2022).","journal-title":"Brain Behav. Immun."},{"key":"7937_CR72","doi-asserted-by":"publisher","first-page":"173106","DOI":"10.1016\/j.pbb.2021.173106","volume":"201","author":"J Navarro-Zaragoza","year":"2021","unstructured":"Navarro-Zaragoza, J. et al. Naloxone-induced conditioned place aversion score and extinction period are higher in C57BL\/6J morphine-dependent mice than in swiss: role of HPA axis. Pharmacol. Biochem. Behav. 201, 173106. https:\/\/doi.org\/10.1016\/j.pbb.2021.173106 (2021).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"7937_CR73","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.pbb.2010.12.003","volume":"98","author":"JL Cobuzzi","year":"2011","unstructured":"Cobuzzi, J. L. & Riley, A. L. Spontaneous withdrawal in opiate-dependent Fischer 344, Lewis and Sprague-Dawley rats. Pharmacol. Biochem. Behav. 98, 28\u201334. https:\/\/doi.org\/10.1016\/j.pbb.2010.12.003 (2011).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"7937_CR74","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.pbb.2008.09.015","volume":"91","author":"M Sadeghi","year":"2009","unstructured":"Sadeghi, M. et al. Study of morphine-induced dependence in gonadectomized male and female mice. Pharmacol. Biochem. Behav. 91, 604\u2013609. https:\/\/doi.org\/10.1016\/j.pbb.2008.09.015 (2009).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"7937_CR75","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0018-506x(84)90051-5","volume":"18","author":"J Broida","year":"1984","unstructured":"Broida, J. & Svare, B. Sex differences in the activity of mice: modulation by postnatal gonadal hormones. Horm. Behav. 18, 65\u201378. https:\/\/doi.org\/10.1016\/0018-506x(84)90051-5 (1984).","journal-title":"Horm. Behav."},{"key":"7937_CR76","doi-asserted-by":"publisher","unstructured":"Hsu, H. T. et al. Hyperbaric oxygen therapy improves Parkinson\u2019s disease by promoting mitochondrial biogenesis via the SIRT-1\/PGC-1alpha pathway. Biomolecules. https:\/\/doi.org\/10.3390\/biom12050661 (2022).","DOI":"10.3390\/biom12050661"},{"key":"7937_CR77","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.jss.2015.04.052","volume":"197","author":"HY Wee","year":"2015","unstructured":"Wee, H. Y. et al. Hyperbaric oxygen effects on neuronal apoptosis associations in a traumatic brain injury rat model. J. Surg. Res. 197, 382\u2013389. https:\/\/doi.org\/10.1016\/j.jss.2015.04.052 (2015).","journal-title":"J. Surg. Res."},{"key":"7937_CR78","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.lfs.2011.11.010","volume":"90","author":"EL Carlile","year":"2012","unstructured":"Carlile, E. L., Shirachi, D. Y. & Quock, R. M. An anxiolytic-like effect of hyperbaric oxygen in the mouse light\/dark exploration test. Life Sci. 90, 267\u2013271. https:\/\/doi.org\/10.1016\/j.lfs.2011.11.010 (2012).","journal-title":"Life Sci."},{"key":"7937_CR79","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.pnpbp.2010.05.016","volume":"34","author":"Y Peng","year":"2010","unstructured":"Peng, Y. et al. Hyperbaric oxygen preconditioning ameliorates anxiety-like behavior and cognitive impairments via upregulation of thioredoxin reductases in stressed rats. Prog Neuropsychopharmacol. Biol. Psychiatry. 34, 1018\u20131025. https:\/\/doi.org\/10.1016\/j.pnpbp.2010.05.016 (2010).","journal-title":"Prog Neuropsychopharmacol. Biol. Psychiatry"},{"key":"7937_CR80","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/10253890.2018.1438405","volume":"21","author":"O Sturman","year":"2018","unstructured":"Sturman, O., Germain, P. L. & Bohacek, J. Exploratory rearing: a context- and stress-sensitive behavior recorded in the open-field test. Stress 21, 443\u2013452. https:\/\/doi.org\/10.1080\/10253890.2018.1438405 (2018).","journal-title":"Stress"},{"key":"7937_CR81","doi-asserted-by":"publisher","unstructured":"Pantazis, C. B. et al. Cues conditioned to withdrawal and negative reinforcement: neglected but key motivational elements driving opioid addiction. Sci. Adv. 7 https:\/\/doi.org\/10.1126\/sciadv.abf0364 (2021).","DOI":"10.1126\/sciadv.abf0364"},{"key":"7937_CR82","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/nn0901-943","volume":"4","author":"DM Hutcheson","year":"2001","unstructured":"Hutcheson, D. M., Everitt, B. J., Robbins, T. W. & Dickinson, A. The role of withdrawal in heroin addiction: enhances reward or promotes avoidance? Nat. Neurosci. 4, 943\u2013947. https:\/\/doi.org\/10.1038\/nn0901-943 (2001).","journal-title":"Nat. Neurosci."},{"issue":"Suppl 1","key":"7937_CR83","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1055\/s-0029-1216356","volume":"42","author":"GF Koob","year":"2009","unstructured":"Koob, G. F. Dynamics of neuronal circuits in addiction: reward, antireward, and emotional memory. Pharmacopsychiatry 42 (Suppl 1), 32\u201341. https:\/\/doi.org\/10.1055\/s-0029-1216356 (2009).","journal-title":"Pharmacopsychiatry"},{"key":"7937_CR84","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1001\/jamapsychiatry.2022.1240","volume":"79","author":"N Vafaie","year":"2022","unstructured":"Vafaie, N. & Kober, H. Association of drug cues and craving with drug use and relapse: A systematic review and Meta-analysis. JAMA Psychiatry. 79, 641\u2013650. https:\/\/doi.org\/10.1001\/jamapsychiatry.2022.1240 (2022).","journal-title":"JAMA Psychiatry"},{"key":"7937_CR85","doi-asserted-by":"publisher","unstructured":"Reiner, D. J. et al. Relapse to opioid seeking in rat models: Behavior, pharmacology and circuits. Neuropsychopharmacology https:\/\/doi.org\/10.1038\/s41386-018-0234-2 (2018).","DOI":"10.1038\/s41386-018-0234-2"},{"key":"7937_CR86","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1002\/jnr.24626","volume":"100","author":"D Reiss","year":"2022","unstructured":"Reiss, D., Maduna, T., Maurin, H., Audouard, E. & Gaveriaux-Ruff, C. Mu opioid receptor in microglia contributes to morphine analgesic tolerance, hyperalgesia, and withdrawal in mice. J. Neurosci. Res. 100, 203\u2013219. https:\/\/doi.org\/10.1002\/jnr.24626 (2022).","journal-title":"J. Neurosci. Res."},{"key":"7937_CR87","doi-asserted-by":"publisher","unstructured":"McDevitt, D. S. et al. The paraventricular thalamic nucleus and its projections in regulating reward and context associations. eNeuro 11 (2024). https:\/\/doi.org\/10.1523\/ENEURO.0524-23.2024","DOI":"10.1523\/ENEURO.0524-23.2024"},{"key":"7937_CR88","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3389\/fnbeh.2014.00117","volume":"8","author":"A Matzeu","year":"2014","unstructured":"Matzeu, A., Zamora-Martinez, E. R. & Martin-Fardon, R. The paraventricular nucleus of the thalamus is recruited by both natural rewards and drugs of abuse: recent evidence of a pivotal role for orexin\/hypocretin signaling in this thalamic nucleus in drug-seeking behavior. Front. Behav. Neurosci. 8, 117. https:\/\/doi.org\/10.3389\/fnbeh.2014.00117 (2014).","journal-title":"Front. Behav. Neurosci."},{"key":"7937_CR89","doi-asserted-by":"publisher","first-page":"109605","DOI":"10.1016\/j.celrep.2021.109605","volume":"36","author":"G Giannotti","year":"2021","unstructured":"Giannotti, G. et al. Extinction blunts paraventricular thalamic contributions to heroin relapse. Cell. Rep. 36, 109605. https:\/\/doi.org\/10.1016\/j.celrep.2021.109605 (2021).","journal-title":"Cell. Rep."},{"key":"7937_CR90","doi-asserted-by":"publisher","unstructured":"Do-Monte, F. H., Minier-Toribio, A., Quinones-Laracuente, K., Medina-Colon, E. M. & Quirk, G. J. Thalamic Regulation of Sucrose Seeking during Unexpected Reward Omission. Neuron 94, 388\u2013400 e384. https:\/\/doi.org\/10.1016\/j.neuron.2017.03.036 (2017).","DOI":"10.1016\/j.neuron.2017.03.036"},{"key":"7937_CR91","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.annemergmed.2019.04.019","volume":"74","author":"A Cragg","year":"2019","unstructured":"Cragg, A. et al. Risk factors for misuse of prescribed opioids: A systematic review and Meta-Analysis. Ann. Emerg. Med. 74, 634\u2013646. https:\/\/doi.org\/10.1016\/j.annemergmed.2019.04.019 (2019).","journal-title":"Ann. Emerg. Med."},{"key":"7937_CR92","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jsat.2017.03.006","volume":"77","author":"YI Hser","year":"2017","unstructured":"Hser, Y. I. et al. Chronic pain among patients with opioid use disorder: results from electronic health records data. J. Subst. Abuse Treat. 77, 26\u201330. https:\/\/doi.org\/10.1016\/j.jsat.2017.03.006 (2017).","journal-title":"J. Subst. Abuse Treat."},{"key":"7937_CR93","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1080\/10550887.2011.581985","volume":"30","author":"LM Carcoba","year":"2011","unstructured":"Carcoba, L. M., Contreras, A. E., Cepeda-Benito, A. & Meagher, M. W. Negative affect heightens opiate withdrawal-induced hyperalgesia in heroin dependent individuals. J. Addict. Dis. 30, 258\u2013270. https:\/\/doi.org\/10.1080\/10550887.2011.581985 (2011).","journal-title":"J. Addict. Dis."},{"key":"7937_CR94","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jsat.2016.08.016","volume":"71","author":"BA Moore","year":"2016","unstructured":"Moore, B. A. et al. Cognitive behavioral therapy improves treatment outcomes for prescription opioid users in primary care buprenorphine treatment. J. Subst. Abuse Treat. 71, 54\u201357. https:\/\/doi.org\/10.1016\/j.jsat.2016.08.016 (2016).","journal-title":"J. Subst. Abuse Treat."},{"key":"7937_CR95","unstructured":"Abuse, N. I. D. Treatment and Recovery (2020). https:\/\/nida.nih.gov\/publications\/drugs-brains-behavior-science-addiction\/treatment-recovery"},{"key":"7937_CR96","doi-asserted-by":"publisher","unstructured":"Zylstra, C. C. et al. Role of nitric oxide (NO) in the hyperbaric oxygen (HBO2)-induced long\u2010lasting activation of endogenous opioid systems in mice. FASEB J. 22 https:\/\/doi.org\/10.1096\/fasebj.22.1_supplement.711.17 (2008).","DOI":"10.1096\/fasebj.22.1_supplement.711.17"},{"key":"7937_CR97","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.jpain.2009.12.004","volume":"11","author":"E Chung","year":"2010","unstructured":"Chung, E., Zelinski, L. M., Ohgami, Y., Shirachi, D. Y. & Quock, R. M. Hyperbaric oxygen treatment induces a 2-phase antinociceptive response of unusually long duration in mice. J. Pain. 11, 847\u2013853. https:\/\/doi.org\/10.1016\/j.jpain.2009.12.004 (2010).","journal-title":"J. Pain"},{"key":"7937_CR98","doi-asserted-by":"publisher","unstructured":"Brewer, A. L., Shirachi, D. Y. & Quock, R. M. Evaluation of hyperbaric oxygen (HBO2) as a treatment for hyperalgesia associated with naloxone-precipitated withdrawal in morphine\u2010dependent mice. FASEB J. 32 https:\/\/doi.org\/10.1096\/fasebj.2018.32.1_supplement.683.4 (2018).","DOI":"10.1096\/fasebj.2018.32.1_supplement.683.4"},{"key":"7937_CR99","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.brainres.2013.08.050","volume":"1537","author":"CR Gibbons","year":"2013","unstructured":"Gibbons, C. R. et al. Involvement of brain opioid receptors in the anti-allodynic effect of hyperbaric oxygen in rats with sciatic nerve crush-induced neuropathic pain. Brain Res. 1537, 111\u2013116. https:\/\/doi.org\/10.1016\/j.brainres.2013.08.050 (2013).","journal-title":"Brain Res."},{"key":"7937_CR100","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.brainres.2010.10.079","volume":"1368","author":"LP Quock","year":"2011","unstructured":"Quock, L. P. et al. The acute antinociceptive effect of HBO(2) is mediated by a NO-cyclic GMP-PKG-KATP channel pathway in mice. Brain Res. 1368, 102\u2013107. https:\/\/doi.org\/10.1016\/j.brainres.2010.10.079 (2011).","journal-title":"Brain Res."},{"key":"7937_CR101","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jpain.2008.08.003","volume":"10","author":"LM Zelinski","year":"2009","unstructured":"Zelinski, L. M., Ohgami, Y., Chung, E., Shirachi, D. Y. & Quock, R. M. A prolonged nitric oxide-dependent, opioid-mediated antinociceptive effect of hyperbaric oxygen in mice. J. Pain. 10, 167\u2013172. https:\/\/doi.org\/10.1016\/j.jpain.2008.08.003 (2009).","journal-title":"J. Pain"},{"key":"7937_CR102","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1177\/147323000403200304","volume":"32","author":"MZ Kiralp","year":"2004","unstructured":"Kiralp, M. Z. et al. Effectiveness of hyperbaric oxygen therapy in the treatment of complex regional pain syndrome. J. Int. Med. Res. 32, 258\u2013262. https:\/\/doi.org\/10.1177\/147323000403200304 (2004).","journal-title":"J. Int. Med. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07937-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07937-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07937-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T20:26:54Z","timestamp":1751488014000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07937-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":102,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7937"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-07937-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"28 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23677"}}